Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fangxia dihuang decoction
- Development stage
- Unknown
- Lead developer
- Xiamen Hospital of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Fangxia Dihuang Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Xiamen Hospital of Traditional Chinese Medicine. It is currently being investigated in Phase 2 clinical trials for the management of psychosomatic symptoms—including anxiety, depression, insomnia, fatigue, and cognitive impairment—in patients with stage II–III breast cancer undergoing postoperative adjuvant chemotherapy. As a decoction, it is a multi-ingredient liquid preparation intended to harmonize the body's internal environment and alleviate the side effects of conventional cancer treatments.
- Other names
- Fangxia Dihuang DecoctionFangxia Dihuang Tang
Beyond the preview
Go deeper on fangxia dihuang decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fangxia dihuang decoction.